NCT00451035 - Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 19, 2007

Primary Completion Date

April 13, 2008

Study Completion Date

September 30, 2008

Conditions

Chronic Myeloid Leukemia in Chronic Phase

Interventions

DRUG

LBH589

Trial Locations (10)

Novartis Investigative Site, Brussels

Novartis Investigative Site, Godinne

Novartis Investigative Site, Leuven

Novartis Investigative Site, Cologne

Novartis Investigative Site, Düsseldorf

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Leipzig

Novartis Investigative Site, Mainz

Novartis Investigative Site, Mannheim

Novartis Investigative Site, Munich